Drug Patent Expirations in December 2010

Drug Patent Expirations in December 2010 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration CHILDREN’S MOTRIN Mcneil Cons ibuprofen 5,215,755*PED Dec 1, 2010 JUNIOR STRENGTH MOTRIN Mcneil Cons ibuprofen 5,215,755*PED Dec 1, 2010 MOTRIN Mcneil Ped ibuprofen 5,215,755*PED Dec 1, 2010 ZYFLO CR Cornerstone Therap zileuton 4,873,259 Dec […]


Patent Expirations Will Stabilize the Pharmaceutical Industry

“Patent Expirations Will Stabilize the Pharmaceutical Industry.” I must believe it, because I’m quoted in the St. Louis Observer as having said it! The reporter did a good job of capturing what I meant, quoting me as saying “the industry will be more diverse, with a more stable, though smaller, revenue base spread among many […]


Journal of Commercial Biotechnology — November 2010 issue now available

The November 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Volume 16, Issue 4 Editorial For success in biotechnology, look beyond biotechnology PDF Yali Friedman Commentary Federal bureaucrats slip on oil spill PDF Henry I Miller Articles R&D spending and […]


Drug Patent Expirations in November 2010

Drug Patent Expirations in November 2010 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration SAMSCA Otsuka America Pharm tolvaptan 5,258,510 Nov 2, 2010 TRUVADA Gilead emtricitabine; tenofovir disoproxil fumarate 5,210,085*PED Nov 11, 2010 COZAAR Merck losartan potassium 5,210,079*PED Nov 11, 2010 EMTRIVA Gilead emtricitabine 5,210,085*PED Nov 11, 2010 […]


Moisture Analysis

Freelance Sarah Webster describes how Biopharma Technology is using laser-based headspace moisture analysis for rapid and non-destructive moisture determination of freeze-dried pharmaceutical products. http://www.manufacturingchemist.com/technical/article_page/Moisture_analysis/55599


Globalization in the pharmaceutical industry: Where are drugs invented?

I’ve just had a paper published in Nature Reviews Drug Discovery, using data from DrugPatentWatch to profile the locations of drug invention for the past decade. The location of drug development is important for two reasons. Firstly, it is important to track the global spread of innovation. Much late stage drug development (e.g. clinical trials) and […]


Bad boards of directors kill more companies than bad management…

A side-comment at the Mid Atlantic Biotech conference really got me thinking. One of the panelists mentioned as an aside that she thought that more companies failed due to bad boards than due to bad management (she preferred not to be named). The board of directors is more than a set of advisors to company […]


Next DCbiotech meeting: Tuesday November 2nd

The next DCbiotech meeting will be at the Marriott Renaissance Washington DC Downtown Hotel on November 2nd  2010. The hotel is at 999 Ninth Street NW, and we’ll be meeting in the Mixx bar from 6:30-8:30pm. To facilitate finding the group, you may want to check out my photo on the about page. Where: Mixx […]


Bringing Better Medicines to Market Faster, an Interview with Expert John Avellanet

Positive reviews of the book, Get to Market Now! Turn FDA Compliance into a Competitive Edge in the Era of Personalized Medicine, have been appearing since the book’s publication earlier this year.  The BiotechBlog sat down with author John Avellanet for a discussion of the book’s appeal. BB:   Why do you think the book is […]


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: